Germany’s medical agency is preparing to announce the results of its cannabis licensing tender later in the coming months, with 13 cultivation and supply bids due to be approved.
The European Union’s largest market has thus far made a pig’s ear of its licensing process, having legalised medicinal cannabis in 2017, but indications are the courts will side with the government over the application process and allow business to resume.
The country’s medical agency has been embroiled in several court cases from disgruntled licensees unhappy at the difficulty of tendering process and its apparent bias towards international players who have more experience in growing and exporting.
Lawyers say the second and hopefully final court battle is nearing an end, allowing BfArM’s (Federal Institute for Drugs and Medical Devices) the grace to hand out licenses and get the party started.
Don’t expect it to be a